Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Fund Creation

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 4
Average round size
info
The average size of a deal this fund participated in
$2M
Portfolio companies 3
Rounds per year 0.21
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.25
Exits 1
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Marketing
  • Health Diagnostics
  • Biopharma
  • Biotechnology
  • CRM
Summary

Fund Creation is the famous VC, which was founded in 2002. The fund was located in Asia if to be more exact in Japan. The main department of described VC is located in the Tokyo.

Among the most popular portfolio startups of the fund, we may highlight REGiMMUNE Corporation. We can highlight the next thriving fund investment areas, such as Biopharma, Biotechnology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Japan. Besides, a startup requires to be at the age of 1 and less years to receive the investment from the fund.

The standard case for the fund is to invest in rounds with 6 partakers. Despite the Fund Creation, startups are often financed by NIF SMBC Ventures, Japan Asia Investment, Yasuda Enterprise Development. The meaningful sponsors for the fund in investment in the same round are Yasuda Enterprise Development, New Cycle Capital, NIF SMBC Ventures. In the next rounds fund is usually obtained by Japan Asia Investment, Yasuda Enterprise Development, NIF SMBC Ventures.

The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2008. The usual things for fund are deals in the range of 5 - 10 millions dollars.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Fund Creation:
Typical Co-investors
Fund Creation is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Fund Creation:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Japan
Funds with similar focus located in Japan:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Abercross Holdings England, London, United Kingdom
AccorHotels France, Ile-de-France, Paris
GLD Invest / GLD Holding AB -
GSA Venture Partners New York, New York, United States
HMW Capital Canada, Ontario, Toronto
Management Gauteng, NA - South Africa, South Africa
Maywic Select Investments Cincinnati, Ohio, United States
Mesa Ventures New York, New York, United States
Middleburg Capital Development Middleburg, United States, Virginia
MYOB Australia, Glen Waverley, Victoria
Myriad Group Switzerland, Zürich, Zurich
Omniscient Beijing, Beijing, China
PLUS Ventures Israel, Ramat Gan, Tel Aviv
Ruihe Zichan China, Shanghai
Sunny Giken Hyogo Prefecture, Itami, Japan
University of Leeds England, Leeds, United Kingdom
Wealth Partners Capital Group Florida, United States, West Palm Beach
Xingmeng Chuangtou China, Hangzhou, Zhejiang
Yukyung PSG Asset Management -
Zhongshan Bison Healthcare Investment Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

REGiMMUNE Corporation

Biopharma
Biotechnology
Health Diagnostics
$6M01 Feb 2008 Chiyoda

REGiMMUNE Corporation

Biopharma
Biotechnology
Health Diagnostics
$4M21 Feb 2007 Chiyoda, Japan

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Fund Creation?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 4
Average round size 2M
Rounds per year 0.21
Peak activity year 2008
Lead investments 0
Follow on index 0.25
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

REGiMMUNE Corporation

Biopharma
Biotechnology
Health Diagnostics
$6M01 Feb 2008 Chiyoda

REGiMMUNE Corporation

Biopharma
Biotechnology
Health Diagnostics
$4M21 Feb 2007 Chiyoda, Japan
Crunchbase icon

Content report

The following text will be sent to our editors: